Ocular Toxicities | Oncology Today with Dr Neil Love: Ocular Toxicities in Patients Receiving Anticancer Therapy

Featuring an interview with Dr Asim Farooq, including the following topics: Educating patients about ocular toxicities associated with anticancer therapies (0:00) Differentiating therapy-related ocular toxicities from symptoms not associated with anticancer drugs (3:44) Optimal prevention of ocular toxicities from antibody-drug conjugates; symptoms and management of central serous retinopathy (9:36) Pathophysiology of ocular symptoms associated with ALK inhibitors and BRAF/MEK inhibitors (16:40) Myths and misperceptions among physicians about ophthalmic toxicities (22:29) CME information and select publications